Medical Condition News

RSS

New therapy from UI Health becomes the first FDA-approved treatment for brittle type 1 diabetes

A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is available exclusively at UI Health in Chicago.

25 Nov 2024

New brain biomarker could enable early diagnosis of psychosis

The current standard of care for psychosis is a diagnostic interview, but what if it could be diagnosed before the first symptom emerged? Researchers at the Del Monte Institute for Neuroscience at the University of Rochester are pointing toward a potential biomarker in the brain that could lead to more timely interventions and personalized care.

25 Nov 2024

Multiomic signatures identified for rapid detection and treatment of high-risk T-ALL

Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the underlying biology that identifies a subset of patients with acute lymphoblastic leukemia who have a higher risk version of the disease and are more likely to relapse despite treatment.

25 Nov 2024

Temozolomide and radiation combination improves survival in low-grade glioma patients

Both radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor activity against slow-growing, low-grade gliomas.

25 Nov 2024

Study highlights barriers to long-term recovery for opioid use disorder patients

A new study led by Thomas Jefferson University researchers highlights critical healthcare gaps that hinder long-term recovery for people living with opioid use disorders (OUD) in Philadelphia.

25 Nov 2024

Knowing your family health history is key to reducing heart attack or stroke risk

Research shows that as much as half of your risk for heart disease can come from your family genes. Experts from the American Heart Association, celebrating a century of lifesaving service as the world's leading nonprofit organization focused on heart and brain health for all, say knowing your family health history is an important step to reducing your risk for a heart attack or stroke.

25 Nov 2024

Targeted intervention substantially boosts colorectal cancer screening rates

Colorectal cancer screening is an effective tool for catching the disease early when it's most treatable, yet it is underutilized in patient populations who receive primary care at federally qualified health centers (FQHC).

25 Nov 2024

Wearable electrical nerve stimulation device can reduce pain and fatigue linked to long COVID

A wearable electrical nerve stimulation device can provide relief to people experiencing the persistent pain and fatigue linked to long COVID, a study co-led by UCLA and Baylor College of Medicine researchers suggests.

25 Nov 2024

Brain volume loss linked to Alzheimer's treatment may be caused by amyloid plaque removal

A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study led by UCL researchers.

25 Nov 2024

Robust measures developed to study how social determinants influence spinal cord injury outcomes

Kessler Foundation researchers have developed robust measures of neighborhood economic factors to study how social determinants influence health outcomes after spinal cord injury (SCI).

25 Nov 2024

IASLC and LCRF announce first grant recipient for lung cancer research

The International Association for the Study of Lung Cancer (IASLC) and The Lung Cancer Research Foundation (LCRF) announce the first grant recipient of the IASLC LCRF Team Science Research Grant on the Next Step in the Cure of Oncogene-Driven Lung Cancers Award.

25 Nov 2024

ASTRO releases updated guidelines for treating locally advanced rectal cancer

The American Society for Radiation Oncology (ASTRO) issued today an updated clinical guideline for physicians who use radiation therapy to treat patients with locally advanced rectal cancer.

25 Nov 2024

History of endometriosis and fibroids linked to higher long-term risk of early death

Researchers examine the impact of endometriosis and uterine fibroids on the risk of early death.

25 Nov 2024

New study offers insights into reliable Alzheimer's diagnosis

A research group at LMU University Hospital has investigated how Alzheimer's disease can be diagnosed more reliably in the future.

25 Nov 2024

Steritas announces collaboration with argenx to advance evidence for novel steroid-sparing therapeutics

Steritas LLC., a company dedicated to enhancing care for steroid-treated patients, today announced a licensing agreement with argenx, a global immunology company, for use of its STOX® Suite of steroid-toxicity clinical outcome assessments (COAs) across argenx's development programs for differentiated immunology therapeutics.

From Steritas LLC 25 Nov 2024

Groundbreaking research sheds light on mitochondrial DNA depletion syndrome

Mitochondrial DNA depletion syndrome (MTDPS) is a rare genetic disorder characterized by a marked decrease in mitochondrial DNA (mtDNA).

25 Nov 2024

Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a licensing agreement for its CHO Edge System with RevOpsis Therapeutics ("RevOpsis"), a next-generation biopharmaceutical company spearheading innovation of multispecific biologics in ophthalmic therapies

From Asimov 25 Nov 2024

Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosis

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today announced the publication of a peer reviewed study in The European Journal of Medicinal Chemistry.

From Enterprise Therapeutics Ltd 25 Nov 2024

Mursla Bio's EvoLiver surpasses current standards in liver cancer surveillance, data presented at AASLD Liver Meeting 2024

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of dynamic biopsy technology, today announced results of its multi-center clinical study, MEV01, in collaboration with leading academic institutes including University College London, Imperial College London, University Hospital of Santa Maria and the Medical University of Graz.

From Mursla Bio 25 Nov 2024

Study points to a strategy for inhibiting hyper-progression of melanoma

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

25 Nov 2024

Medical Condition News

New therapy from UI Health becomes the first FDA-approved treatment for brittle type 1 diabetes

New brain biomarker could enable early diagnosis of psychosis

Multiomic signatures identified for rapid detection and treatment of high-risk T-ALL

Temozolomide and radiation combination improves survival in low-grade glioma patients

Study highlights barriers to long-term recovery for opioid use disorder patients

Knowing your family health history is key to reducing heart attack or stroke risk

Targeted intervention substantially boosts colorectal cancer screening rates

Wearable electrical nerve stimulation device can reduce pain and fatigue linked to long COVID

Brain volume loss linked to Alzheimer's treatment may be caused by amyloid plaque removal

Robust measures developed to study how social determinants influence spinal cord injury outcomes

IASLC and LCRF announce first grant recipient for lung cancer research

ASTRO releases updated guidelines for treating locally advanced rectal cancer

History of endometriosis and fibroids linked to higher long-term risk of early death

New study offers insights into reliable Alzheimer's diagnosis

Steritas announces collaboration with argenx to advance evidence for novel steroid-sparing therapeutics

Groundbreaking research sheds light on mitochondrial DNA depletion syndrome

Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line

Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosis

Mursla Bio's EvoLiver surpasses current standards in liver cancer surveillance, data presented at AASLD Liver Meeting 2024

Study points to a strategy for inhibiting hyper-progression of melanoma

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News